HIGHLIGHTS
- who: John Olichney and colleagues from the Center for Mind and Brain, University of California, Davis, Davis, CA, USA have published the research: Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event- Related Potential, in the Journal: Neural Plasticity of 10/06/2022
- what: The review focuses on the P300 component of the ERP waveform, including important technical aspects of the methodology, and summarizes the existing evidence of its translational utility in evaluating potential procognitive properties of pharmaceutical interventions in AD, other neurodegenerative diseases, and neuropsychiatric disorders.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.